SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE: Form 990, tax year 2016
View the entire original 990 at ProPublica ↗
- Organization
- SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE (EIN 51-0197108)
- Tax period
- 2016-07-01 to 2017-06-30
- Filed
- 2018-05-11
- IRS object ID
- 201811319349304326
- Schema version
- 2016v3.1
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule G
- Schedule J
- Schedule K
- Schedule L
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2018-05-11T16:16:00-05:00 | ReturnTs |
| Tax Period End | 2017-06-30 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ERNST & YOUNG US LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 4365 EXECUTIVE DRIVE STE 1600 | AddressLine1Txt |
| City | SAN DIEGO | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 92121 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2016-07-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 510197108 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY | BusinessNameLine1Txt |
| Business Name Line2 | INSTITUTE | BusinessNameLine2Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| In Care Of | % GARY CHESSUM | InCareOfNm |
| Business Name Control | SANF | BusinessNameControlTxt |
| Phone | 8586463100 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 10901 North Torrey Pines Road | AddressLine1Txt |
| City | La Jolla | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 92037 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | GARY CHESSUM | PersonNm |
| Person Title | CFO | PersonTitleTxt |
| Phone | 8586463100 | PhoneNum |
| Signature | 2018-05-11 | SignatureDt |
| Discuss With Paid Preparer | Yes (true) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | DEBRA HEISKALA | PreparerPersonNm |
| PTIN | P00649485 | PTIN |
| Phone | 8585357200 | PhoneNum |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2016 | TaxYr |
| Build TS | 2022-09-23 18:48:47Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | Kristiina Vuori | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 10901 North Torrey Pines Road | AddressLine1Txt |
| City | La Jolla | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 92037 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $340,385,736 | GrossReceiptsAmt |
| Group Return For Affiliates | false | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | www.sbpdiscovery.org | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1976 | FormationYr |
| Legal Domicile State | CA | LegalDomicileStateCd |
| Activity Or Mission | SEE SCHEDULE O | ActivityOrMissionDesc |
| Voting Members Governing Body | 22 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 20 | VotingMembersIndependentCnt |
| Total Employee | 983 | TotalEmployeeCnt |
| Total Volunteers | 25 | TotalVolunteersCnt |
| Total Gross UBI | $2,133,255 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $281,883 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $112,687,922 | PYContributionsGrantsAmt |
| CY Contributions Grants | $121,777,889 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $1,984,033 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $1,413,894 | CYProgramServiceRevenueAmt |
| PY Investment Income | $9,787,422 | PYInvestmentIncomeAmt |
| CY Investment Income | $5,628,894 | CYInvestmentIncomeAmt |
| PY Other Revenue | $4,645,694 | PYOtherRevenueAmt |
| CY Other Revenue | $5,353,488 | CYOtherRevenueAmt |
| PY Total Revenue | $129,105,071 | PYTotalRevenueAmt |
| CY Total Revenue | $134,174,165 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $0 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $0 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $77,528,317 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $79,341,143 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $1,574,342 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $64,840,277 | PYOtherExpensesAmt |
| CY Other Expenses | $67,504,171 | CYOtherExpensesAmt |
| PY Total Expenses | $142,368,594 | PYTotalExpensesAmt |
| CY Total Expenses | $146,845,314 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | -$13,263,523 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | -$12,671,149 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $517,058,113 | TotalAssetsBOYAmt |
| Total Assets EOY | $482,051,570 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $207,862,462 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $174,862,590 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $309,195,651 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $307,188,980 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | SEE SCHEDULE O | MissionDesc |
| Significant New Program Srvc | false | SignificantNewProgramSrvcInd |
| Significant Change | false | SignificantChangeInd |
| Expense | $119,849,856 | ExpenseAmt |
| Grant | $0 | GrantAmt |
| Revenue | $1,700,572 | RevenueAmt |
| Desc | SEE SCHEDULE O | Desc |
| Total Program Service Expenses | $119,849,856 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (true) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (true) | ScheduleBRequiredInd |
| Political Campaign Acty | false | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (true) | LobbyingActivitiesInd |
| Subject To Proxy Tax | false | SubjectToProxyTaxInd |
| Donor Advised Fund | false | DonorAdvisedFundInd |
| Conservation Easements | false | ConservationEasementsInd |
| Collections Of Art | false | CollectionsOfArtInd |
| Credit Counseling | false | CreditCounselingInd |
| Temp Or Permanent Endowments | Yes (true) | TempOrPermanentEndowmentsInd |
| Report Land Building Equipment | Yes (true) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | false | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | false | ReportProgramRelatedInvstInd |
| Report Other Assets | false | ReportOtherAssetsInd |
| Report Other Liabilities | false | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (true) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (true) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | false | ConsolidatedAuditFinclStmtInd |
| School Operating | false | SchoolOperatingInd |
| Foreign Office | Yes (true) | ForeignOfficeInd |
| Foreign Activities | Yes (true) | ForeignActivitiesInd |
| More Than5000 K To Org | false | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | false | MoreThan5000KToIndividualsInd |
| Professional Fundraising | false | ProfessionalFundraisingInd |
| Fundraising Activities | Yes (true) | FundraisingActivitiesInd |
| Gaming Activities | false | GamingActivitiesInd |
| Operate Hospital | false | OperateHospitalInd |
| Grants To Organizations | false | GrantsToOrganizationsInd |
| Grants To Individuals | false | GrantsToIndividualsInd |
| Schedule J Required | Yes (true) | ScheduleJRequiredInd |
| Tax Exempt Bonds | Yes (true) | TaxExemptBondsInd |
| Invest Tax Exempt Bonds | false | InvestTaxExemptBondsInd |
| Escrow Account | false | EscrowAccountInd |
| On Behalf Of Issuer | false | OnBehalfOfIssuerInd |
| Engaged In Excess Benefit Trans | false | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | false | PYExcessBenefitTransInd |
| Loan Outstanding | Yes (true) | LoanOutstandingInd |
| Grant To Related Person | false | GrantToRelatedPersonInd |
| Business Rln With Org Mem | false | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | false | BusinessRlnWithFamMemInd |
| Business Rln With Officer Ent | false | BusinessRlnWithOfficerEntInd |
| Deductible Non Cash Contri | false | DeductibleNonCashContriInd |
| Deductible Art Contribution | false | DeductibleArtContributionInd |
| Terminate Operations | false | TerminateOperationsInd |
| Partial Liquidation | false | PartialLiquidationInd |
| Disregarded Entity | false | DisregardedEntityInd |
| Related Entity | Yes (true) | RelatedEntityInd |
| Related Organization Ctrl Ent | Yes (true) | RelatedOrganizationCtrlEntInd |
| Transaction With Control Ent | false | TransactionWithControlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | false | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | false | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (true) | ScheduleORequiredInd |
| IRP Document | 229 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (true) | BackupWthldComplianceInd |
| Employee | 983 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (true) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | Yes (true) | UnrelatedBusIncmOverLimitInd |
| Form990 T Filed | Yes (true) | Form990TFiledInd |
| Foreign Financial Account | false | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | false | TaxablePartyNotificationInd |
| Nondeductible Contributions | false | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | Yes (true) | QuidProQuoContributionsInd |
| Quid Pro Quo Contri Discl | Yes (true) | QuidProQuoContriDisclInd |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | false | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | false | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | false | IndoorTanningServicesInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 22 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 20 | IndependentVotingMemberCnt |
| Family Or Business Rln | false | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | false | DelegationOfMgmtDutiesInd |
| Change To Org Documents | false | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | false | MembersOrStockholdersInd |
| Election Of Board Members | false | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | false | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (true) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (true) | MinutesOfCommitteesInd |
| Officer Mailing Address | false | OfficerMailingAddressInd |
| Local Chapters | false | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (true) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (true) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (true) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (true) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (true) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (true) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (true) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (true) | CompensationProcessOtherInd |
| Investment In Joint Venture | false | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | AL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CO | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | DC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | FL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | GA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ME | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MD | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NJ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NM | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ND | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | PA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | RI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | SC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | UT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WV | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WI | StatesWhereCopyOfReturnIsFldCd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | GARY CHESSUM | PersonNm |
| Phone | 8586463100 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 10901 N TORREY PINES RD | AddressLine1Txt |
| City | LA JOLLA | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 92037 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (35 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Highest Compensated EmployeeHighestCompensatedEmployeeInd | Former Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd |
|---|---|---|---|---|---|---|---|---|---|
| PERRY NISEN MD PHD | |||||||||
| CEO | 50.0 | 0.0 | Yes (X) | Yes (X) | $1,115,133 | $0 | $122,179 | ||
| DOUGLAS OBENSHAIN | |||||||||
| TRUSTEE | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| BERNARD MACHEN | |||||||||
| TRUSTEE (PART YEAR) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| DAVID DOWN | |||||||||
| TRUSTEE | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| WILLIAM GERHART | |||||||||
| TRUSTEE | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| RASESH THAKKAR | |||||||||
| TRUSTEE (PART YEAR) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| LUDER WHITLOCK | |||||||||
| TRUSTEE | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| LORENZO BERHO | |||||||||
| TRUSTEE | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| DANIEL EPSTEIN | |||||||||
| TRUSTEE | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| WAINWRIGHT FISHBURN | |||||||||
| TRUSTEE | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| PATRICK GERAGHTY | |||||||||
| TRUSTEE (PART YEAR) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| ALAN GLEICHER | |||||||||
| TRUSTEE | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| JEANNE HERBERGER | |||||||||
| TRUSTEE | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| DONALD JERNIGAN | |||||||||
| TRUSTEE | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| DOUG MANCHESTER | |||||||||
| TRUSTEE (PART YEAR) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| EDWARD SCHULAK | |||||||||
| TRUSTEE | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| STUART TANZ | |||||||||
| TRUSTEE | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| CAROL GALLAGHER | |||||||||
| TRUSTEE | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| GREG LUCIER | |||||||||
| TRUSTEE | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| JAMES JARDON | |||||||||
| TRUSTEE | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| DONALD ROSENBERG | |||||||||
| TRUSTEE | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| JAMES MYERS | |||||||||
| TRUSTEE | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| KAZUMI SHIOSAKI | |||||||||
| TRUSTEE | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| HENRY NORDOFF | |||||||||
| CHAIRMAN | 1.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| JAMES BLAIR | |||||||||
| VICE CHAIR | 1.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| KRISTIINA VUORI MD PHD | |||||||||
| PRESIDENT | 50.0 | 0.0 | Yes (X) | Yes (X) | $886,682 | $0 | $565,924 | ||
| PAULINE FOSTER | |||||||||
| TRUSTEE (PART YEAR) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| KNOX BELL | |||||||||
| CORPORATE SECRETARY | 2.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| GARY CHESSUM | |||||||||
| CFO | 50.0 | 0.0 | Yes (X) | $418,910 | $0 | $36,262 | |||
| GARTH POWIS PHD | |||||||||
| CENTER DIRECTOR | 50.0 | 0.0 | $503,978 | $0 | $42,359 | Yes (X) | |||
| DANIEL KELLY MD | |||||||||
| CNTR DIR/SCI DIR AT LK NONA | 50.0 | 0.0 | $502,023 | $0 | $50,731 | Yes (X) | |||
| EDWARD LEWANDOWSKI | |||||||||
| PROFESSOR | 50.0 | 0.0 | $518,581 | $0 | $23,914 | Yes (X) | |||
| CARL WARE PHD | |||||||||
| CENTER DIRECTOR, IIDC | 50.0 | 0.0 | $417,535 | $0 | $42,616 | Yes (X) | |||
| MICHAEL JACKSON PHD | |||||||||
| DRUG DISCOVERY & DEV, SR VP | 50.0 | 0.0 | $433,071 | $0 | $50,455 | Yes (X) | |||
| GARY RAISL ED D | |||||||||
| FORMER EVP/CAO/CFP/TREASURER | 0.0 | 0.0 | $365,372 | $0 | $0 | Yes (X) | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $5,161,285 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $934,440 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 142 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | Yes (true) | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (true) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | false | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| DLA PIPER US LLP | |||||
| PO Box 64029 | Baltimore | MD | 21264 | Legal SERVICES | $634,757 |
| Deloitte Touche LLP | |||||
| PO BOX 844708 | DALLAS | TX | 75284 | Audit SERVICES | $191,957 |
| Pabst Patent Group LLP | |||||
| 1545 Peachtree Stree NE Ste 320 | Atlanta | GA | 30309 | Legal SERVICES | $140,269 |
| Kenneth Widder | |||||
| PO BOX 676250 | RANCHO SANTA FE | CA | 92067 | Consulting SERVICES | $118,350 |
| Wilson Sonsini Goodrich | |||||
| PO BOX 742866 | Los Angeles | CA | 90074 | Legal SERVICES | $111,891 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 5 | CntrctRcvdGreaterThan100KCnt |
| Fundraising | $711,165 | FundraisingAmt |
| Government Grants | $74,902,971 | GovernmentGrantsAmt |
| All Other Contributions | $46,163,753 | AllOtherContributionsAmt |
| Noncash Contributions | $0 | NoncashContributionsAmt |
| Total Contributions | $121,777,889 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | SHARED SERVICES REVENUE | Desc |
| Business | 541990 | BusinessCd |
| Total Revenue Column | $1,413,894 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $1,413,894 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $0 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $1,413,894 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $3,146,953 | TotalRevenueColumnAmt |
| Unrelated Business Revenue | $3,890 | UnrelatedBusinessRevenueAmt |
| Exclusion | $3,143,063 | ExclusionAmt |
Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $3,138,128 | TotalRevenueColumnAmt |
| Exclusion | $3,138,128 | ExclusionAmt |
Gross Rents GrossRentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $22,560 | RealAmt |
Rental Income Or Loss RentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $22,560 | RealAmt |
| Personal | $0 | PersonalAmt |
Net Rental Income Or Loss NetRentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $22,560 | TotalRevenueColumnAmt |
| Exclusion | $22,560 | ExclusionAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $208,413,269 | SecuritiesAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $205,931,328 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $2,481,941 | SecuritiesAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $2,481,941 | TotalRevenueColumnAmt |
| Exclusion | $2,481,941 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $57,000 | FundraisingGrossIncomeAmt |
| Contri Rpt Fundraising Event | $711,165 | ContriRptFundraisingEventAmt |
| Fundraising Direct Expenses | $280,243 | FundraisingDirectExpensesAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$223,243 | TotalRevenueColumnAmt |
| Exclusion | -$223,243 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gaming Gross Income | $0 | GamingGrossIncomeAmt |
| Gaming Direct Expenses | $0 | GamingDirectExpensesAmt |
Net Income From Gaming NetIncomeFromGamingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Sales Of Inventory | $0 | GrossSalesOfInventoryAmt |
| Cost Of Goods Sold | $0 | CostOfGoodsSoldAmt |
Net Income Or Loss NetIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Other Revenue Misc OtherRevenueMiscGrp (3 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt | Unrelated Business RevenueUnrelatedBusinessRevenueAmt | ExclusionExclusionAmt |
|---|---|---|---|---|---|
| Research | 541700 | $2,129,365 | $0 | $2,129,365 | $0 |
| OTHER RESEARCH SUPPORT | 541990 | $153,475 | $153,475 | $0 | $0 |
| Sale of Reagents | 541990 | $59,006 | $59,006 | $0 | $0 |
Miscellaneous Revenue MiscellaneousRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $74,197 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $74,197 | RelatedOrExemptFuncIncomeAmt |
| Exclusion | $0 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $2,416,043 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $134,174,165 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $1,700,572 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $2,133,255 | UnrelatedBusinessRevenueAmt |
| Exclusion | $8,562,449 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
Benefits To Members BenefitsToMembersGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,391,383 | TotalAmt |
| Program Services | $243,210 | ProgramServicesAmt |
| Management And General | $2,148,173 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Comp Disqual Persons CompDisqualPersonsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Management And General | $0 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $60,650,213 | TotalAmt |
| Program Services | $48,931,572 | ProgramServicesAmt |
| Management And General | $10,917,314 | ManagementAndGeneralAmt |
| Fundraising | $801,327 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,977,082 | TotalAmt |
| Program Services | $3,252,754 | ProgramServicesAmt |
| Management And General | $675,228 | ManagementAndGeneralAmt |
| Fundraising | $49,100 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $8,692,549 | TotalAmt |
| Program Services | $7,145,436 | ProgramServicesAmt |
| Management And General | $1,442,886 | ManagementAndGeneralAmt |
| Fundraising | $104,227 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,629,916 | TotalAmt |
| Program Services | $2,821,696 | ProgramServicesAmt |
| Management And General | $751,430 | ManagementAndGeneralAmt |
| Fundraising | $56,790 | FundraisingAmt |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,755,607 | TotalAmt |
| Program Services | $940,071 | ProgramServicesAmt |
| Management And General | $743,178 | ManagementAndGeneralAmt |
| Fundraising | $72,358 | FundraisingAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,069,842 | TotalAmt |
| Program Services | $52,701 | ProgramServicesAmt |
| Management And General | $1,017,141 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $400,371 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
| Management And General | $400,371 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $67,275 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
| Management And General | $67,275 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Fees For Services Prof Fundraising FeesForServicesProfFundraising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Fundraising | $0 | FundraisingAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $15,100 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
| Management And General | $15,100 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,508,777 | TotalAmt |
| Program Services | $710,539 | ProgramServicesAmt |
| Management And General | $783,576 | ManagementAndGeneralAmt |
| Fundraising | $14,662 | FundraisingAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $56,734 | TotalAmt |
| Program Services | $3,155 | ProgramServicesAmt |
| Management And General | $7,777 | ManagementAndGeneralAmt |
| Fundraising | $45,802 | FundraisingAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $8,813,036 | TotalAmt |
| Program Services | $7,869,629 | ProgramServicesAmt |
| Management And General | $845,653 | ManagementAndGeneralAmt |
| Fundraising | $97,754 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,401,290 | TotalAmt |
| Program Services | $1,102,617 | ProgramServicesAmt |
| Management And General | $263,472 | ManagementAndGeneralAmt |
| Fundraising | $35,201 | FundraisingAmt |
Royalties RoyaltiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
| Management And General | $0 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $13,450,575 | TotalAmt |
| Program Services | $12,058,762 | ProgramServicesAmt |
| Management And General | $1,307,241 | ManagementAndGeneralAmt |
| Fundraising | $84,572 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $554,902 | TotalAmt |
| Program Services | $457,532 | ProgramServicesAmt |
| Management And General | $93,631 | ManagementAndGeneralAmt |
| Fundraising | $3,739 | FundraisingAmt |
Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
| Management And General | $0 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,193,091 | TotalAmt |
| Program Services | $877,587 | ProgramServicesAmt |
| Management And General | $284,224 | ManagementAndGeneralAmt |
| Fundraising | $31,280 | FundraisingAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,162,878 | TotalAmt |
| Program Services | $1,961,514 | ProgramServicesAmt |
| Management And General | $183,412 | ManagementAndGeneralAmt |
| Fundraising | $17,952 | FundraisingAmt |
Payments To Affiliates PaymentsToAffiliatesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
| Management And General | $0 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $13,127,059 | TotalAmt |
| Program Services | $11,843,510 | ProgramServicesAmt |
| Management And General | $1,225,692 | ManagementAndGeneralAmt |
| Fundraising | $57,857 | FundraisingAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $146,793 | TotalAmt |
| Management And General | $146,793 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt | FundraisingFundraisingAmt |
|---|---|---|---|---|
| RESEARCH SUPPLIES & SERV. | $14,706,631 | $14,706,631 | $0 | $0 |
| Scientific collaborations | $4,567,950 | $4,567,950 | $0 | $0 |
| Recruitment | $250,018 | $189,837 | $60,065 | $116 |
| Bad Debt | $1,891,263 | $0 | $1,891,263 | $0 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $364,979 | TotalAmt |
| Program Services | $113,153 | ProgramServicesAmt |
| Management And General | $150,221 | ManagementAndGeneralAmt |
| Fundraising | $101,605 | FundraisingAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $146,845,314 | TotalAmt |
| Program Services | $119,849,856 | ProgramServicesAmt |
| Management And General | $25,421,116 | ManagementAndGeneralAmt |
| Fundraising | $1,574,342 | FundraisingAmt |
Total Joint Costs TotalJointCostsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,123,683 | BOYAmt |
| EOY | $4,468,804 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $23,499,833 | BOYAmt |
| EOY | $21,504,849 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $60,764,502 | BOYAmt |
| EOY | $36,509,300 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,160,298 | BOYAmt |
| EOY | $854,298 | EOYAmt |
Receivables From Officers Etc ReceivablesFromOfficersEtcGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,184,978 | BOYAmt |
| EOY | $1,137,581 | EOYAmt |
Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,596,813 | BOYAmt |
| EOY | $1,160,303 | EOYAmt |
Inventories For Sale Or Use InventoriesForSaleOrUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $214,481 | BOYAmt |
| EOY | $177,124 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $6,963,036 | BOYAmt |
| EOY | $6,858,015 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $306,494,829 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $171,993,087 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $139,163,665 | BOYAmt |
| EOY | $134,501,742 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $263,938,102 | BOYAmt |
| EOY | $256,843,206 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $11,800,000 | BOYAmt |
| EOY | $15,556,694 | EOYAmt |
Investments Program Related InvestmentsProgramRelatedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Intangible Assets IntangibleAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,648,722 | BOYAmt |
| EOY | $2,479,654 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $517,058,113 | BOYAmt |
| EOY | $482,051,570 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $18,662,124 | BOYAmt |
| EOY | $16,961,878 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $124,792,172 | BOYAmt |
| EOY | $96,699,380 | EOYAmt |
Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $64,408,166 | BOYAmt |
| EOY | $61,201,332 | EOYAmt |
Escrow Account Liability EscrowAccountLiabilityGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Loans From Officers Directors LoansFromOfficersDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $207,862,462 | BOYAmt |
| EOY | $174,862,590 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows SFAS117 | Yes (X) | OrganizationFollowsSFAS117Ind |
Unrestricted Net Assets UnrestrictedNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $138,987,303 | BOYAmt |
| EOY | $180,035,528 | EOYAmt |
Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $156,181,232 | BOYAmt |
| EOY | $113,099,936 | EOYAmt |
Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $14,027,116 | BOYAmt |
| EOY | $14,053,516 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $309,195,651 | BOYAmt |
| EOY | $307,188,980 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $517,058,113 | BOYAmt |
| EOY | $482,051,570 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | -$12,671,149 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | $10,664,478 | NetUnrlzdGainsLossesInvstAmt |
| Donated Services And Use Fclts | $0 | DonatedServicesAndUseFcltsAmt |
| Prior Period Adjustments | $0 | PriorPeriodAdjustmentsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | false | AccountantCompileOrReviewInd |
| FS Audited | Yes (true) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Separate Basis Fincl Stmt | Yes (X) | SeparateBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (true) | AuditCommitteeInd |
| Federal Grant Audit Required | Yes (true) | FederalGrantAuditRequiredInd |
| Federal Grant Audit Performed | Yes (true) | FederalGrantAuditPerformedInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $146,497,371 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $146,698,221 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $244,026,040 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $112,703,072 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $121,777,889 | CurrentTaxYearAmt |
| Total | $771,702,593 | TotalAmt |
Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $146,497,371 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $146,698,221 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $244,026,040 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $112,703,072 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $121,777,889 | CurrentTaxYearAmt |
| Total | $771,702,593 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $83,084,132 | SubstantialContributorsTotAmt |
| Public Support Total170 | $688,618,461 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $4,000,400 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $4,044,153 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $6,992,391 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $5,532,193 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $6,303,751 | CurrentTaxYearAmt |
| Total | $26,872,888 | TotalAmt |
Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $144,833 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $195,599 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $160,548 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $52,137 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $281,883 | CurrentTaxYearAmt |
| Total | $835,000 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $799,410,481 | TotalSupportAmt |
| Gross Receipts Rltd Activities | $8,984,298 | GrossReceiptsRltdActivitiesAmt |
| Public Support CY170 | 0.86141 | PublicSupportCY170Pct |
| Public Support PY170 | 0.85459 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Grassroots Lobbying | TotalGrassrootsLobbyingGrp | |
| Total Direct Lobbying | TotalDirectLobbyingGrp | |
| Total Lobbying Expend | TotalLobbyingExpendGrp | |
| Other Exempt Purpose Expend | OtherExemptPurposeExpendGrp | |
| Total Exempt Purpose Expend | TotalExemptPurposeExpendGrp | |
| Lobbying Nontaxable Amount | LobbyingNontaxableAmountGrp | |
| Grassroots Nontaxable | GrassrootsNontaxableGrp | |
| Tot Lbbyng Grassroot Mns Non Tx | TotLbbyngGrassrootMnsNonTxGrp | |
| Tot Lbby Expend Mns Lbbyng Non Tx | TotLbbyExpendMnsLbbyngNonTxGrp | |
| Volunteers | false | VolunteersInd |
| Paid Staff Or Management | false | PaidStaffOrManagementInd |
| Media Advertisements | false | MediaAdvertisementsInd |
| Media Advertisements | $0 | MediaAdvertisementsAmt |
| Mailings Members | false | MailingsMembersInd |
| Mailings Members | $0 | MailingsMembersAmt |
| Publications Or Broadcast | false | PublicationsOrBroadcastInd |
| Publications Or Broadcast | $0 | PublicationsOrBroadcastAmt |
| Grants Other Organizations | false | GrantsOtherOrganizationsInd |
| Grants Other Organizations | $0 | GrantsOtherOrganizationsAmt |
| Direct Contact Legislators | Yes (true) | DirectContactLegislatorsInd |
| Direct Contact Legislators | $87,006 | DirectContactLegislatorsAmt |
| Rallies Demonstrations | false | RalliesDemonstrationsInd |
| Rallies Demonstrations | $0 | RalliesDemonstrationsAmt |
| Other Activities | Yes (true) | OtherActivitiesInd |
| Other Activities | $62,775 | OtherActivitiesAmt |
| Total Lobbying Expenditures | $149,781 | TotalLobbyingExpendituresAmt |
| Not Described Section501c3 | false | NotDescribedSection501c3Ind |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| SCHEDULE C, PART II-B, LINE 1G | LOBBYING ACTIVITIES CONTACT AND MEET WITH FEDERAL AND STATE LEGISLATORS AND THEIR STAFF TO SEEK POTENTIAL RESEARCH FUNDING. |
| SCHEDULE C, PART II-B, LINE 1I | OTHER ACTIVITIES DUES TO RESEARCH AND BIOMEDICAL ORGANIZATIONS, A PORTION OF WHICH ARE CONSIDERED LOBBYING. THE INSTITUTE UTILIZES ATLANTIC STRATEGIES GROUP, LLC FOR REPRESENTATION IN WASHINGTON DC, TO INVESTIGATE AND SEEK POTENTIAL FEDERAL RESEARCH FUNDING OPPORTUNITIES OUTSIDE THE TRADITIONAL NIH PROCESS. THE INSTITUTE CONTRACTS WITH CAPITAL INSIGHT AND ASSOCIATES FOR REPRESENTATION IN TALLAHASSEE, FL, TO INVESTIGATE AND SEEK POTENTIAL STATE RESEARCH FUNDING OPPORTUNITIES. |
Schedule D IRS990ScheduleD
| Field | Value | IRS element (for citing) |
|---|---|---|
| Art Public Exhibition Amounts | ArtPublicExhibitionAmountsGrp | |
| Held Works Art | HeldWorksArtGrp |
CY Endwmt Fund CYEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $25,987,641 | BeginningYearBalanceAmt |
| Contributions | $530,336 | ContributionsAmt |
| Investment Earnings Or Losses | $3,395,420 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $1,232,083 | OtherExpendituresAmt |
| End Year Balance | $28,681,314 | EndYearBalanceAmt |
CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $26,693,919 | BeginningYearBalanceAmt |
| Contributions | $510,067 | ContributionsAmt |
| Investment Earnings Or Losses | -$3,125 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $1,213,220 | OtherExpendituresAmt |
| End Year Balance | $25,987,641 | EndYearBalanceAmt |
CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $26,870,514 | BeginningYearBalanceAmt |
| Contributions | $920,000 | ContributionsAmt |
| Investment Earnings Or Losses | $36,749 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $1,133,344 | OtherExpendituresAmt |
| End Year Balance | $26,693,919 | EndYearBalanceAmt |
CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $22,805,011 | BeginningYearBalanceAmt |
| Contributions | $1,310,000 | ContributionsAmt |
| Investment Earnings Or Losses | $3,778,222 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $1,022,719 | OtherExpendituresAmt |
| End Year Balance | $26,870,514 | EndYearBalanceAmt |
CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $21,200,471 | BeginningYearBalanceAmt |
| Contributions | $9,000 | ContributionsAmt |
| Investment Earnings Or Losses | $2,517,312 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $921,772 | OtherExpendituresAmt |
| End Year Balance | $22,805,011 | EndYearBalanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Board Designated Balance EOY | 0.46130 | BoardDesignatedBalanceEOYPct |
| Prmnnt Endowment Balance EOY | 0.47220 | PrmnntEndowmentBalanceEOYPct |
| Term Endowment Balance EOY | 0.06650 | TermEndowmentBalanceEOYPct |
| Endowments Held Unrelated Org | false | EndowmentsHeldUnrelatedOrgInd |
| Endowments Held Related Org | false | EndowmentsHeldRelatedOrgInd |
Land LandGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $25,793,087 | OtherCostOrOtherBasisAmt |
| Book Value | $25,793,087 | BookValueAmt |
Buildings BuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $166,575,980 | OtherCostOrOtherBasisAmt |
| Depreciation | $79,374,694 | DepreciationAmt |
| Book Value | $87,201,286 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Leasehold Improvements | LeaseholdImprovementsGrp |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $113,578,127 | OtherCostOrOtherBasisAmt |
| Depreciation | $92,618,393 | DepreciationAmt |
| Book Value | $20,959,734 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $547,635 | OtherCostOrOtherBasisAmt |
| Book Value | $547,635 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $134,501,742 | TotalBookValueLandBuildingsAmt |
| Federal Income Tax Liability | $0 | FederalIncomeTaxLiabilityAmt |
| Total Liability | $0 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $144,824,000 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | $10,664,478 | NetUnrealizedGainsInvstAmt |
| Other Revenue | $457 | OtherRevenueAmt |
| Revenue Not Reported | $10,664,935 | RevenueNotReportedAmt |
| Revenue Subtotal | $134,159,065 | RevenueSubtotalAmt |
| Investment Expenses Not Incld | $15,100 | InvestmentExpensesNotIncldAmt |
| Other Revenues Not Included | $0 | OtherRevenuesNotIncludedAmt |
| Revenue Not Reported Fincl Stmt | $15,100 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $134,174,165 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $146,830,000 | TotExpnsEtcAuditedFinclStmtAmt |
| Other Expenses Included | $0 | OtherExpensesIncludedAmt |
| Expenses Not Reported | $0 | ExpensesNotReportedAmt |
| Expenses Subtotal | $146,830,000 | ExpensesSubtotalAmt |
| Investment Expenses Not Incld2 | $15,100 | InvestmentExpensesNotIncld2Amt |
| Other Expenses Not Included | $214 | OtherExpensesNotIncludedAmt |
| Expenses Not Rpt Fincl Stmt | $15,314 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $146,845,314 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (4 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| SCHEDULE D, PART V, LINE 4 | INTENDED USES OF THE ORGANIZATION'S ENDOWMENT FUNDS THE INSTITUTE'S ENDOWMENT FUNDS ARE ESTABLISHED FOR VARIOUS PURPOSES: SCIENTIFIC RESEARCH, CEO CHAIR, PRESIDENTIAL CHAIR, CANCER AND NEUROSCIENCE LEADERSHIP CHAIRS, AND UNRESTRICTED AS TO INCOME. |
| SCHEDULE D, PART X, LINE 2 | FIN 48 (ASC 740) FOOTNOTE THE INSTITUTE HAS NO MATERIAL DEFERRED TAX ASSETS OR DEFERRED TAX LIABILITIES RECORDED AS OF JUNE 30, 2017 AND 2016. THE INSTITUTE DID NOT RECOGNIZE A CHANGE IN LIABILITY FOR UNRECOGNIZED TAX BENEFITS (THE DIFFERENCE BETWEEN A TAX POSITION TAKEN, OR EXPECTED TO BE TAKEN, IN A TAX RETURN AND THE BENEFIT RECOGNIZED AND MEASURED IN THE FINANCIAL STATEMENTS). THERE WERE NO LIABILITIES FOR UNRECOGNIZED TAX BENEFITS AT JUNE 30, 2017 AND 2016. |
| SCHEDULE D, PART XI, LINE 2D | ROUNDING - 457 |
| SCHEDULE D, PART XII, LINE 4B | ROUNDING - 214 |
Schedule F IRS990ScheduleF
Account Activities Outside US AccountActivitiesOutsideUSGrp (8 entries)
| RegionRegionTxt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|---|
| Europe (Including Iceland and Greenland) | 49 | Program Services | See Part V | $107,967 |
| East Asia and the Pacific | 15 | Program Services | See Part V | $39,000 |
| North America | 4 | Program Services | See Part V | $2,311 |
| South Asia | 2 | Program Services | See Part V | $9,006 |
| Middle East and North Africa | 4 | Program Services | See Part V | $8,411 |
| Russia and the Newly Independent States | 1 | Program Services | See Part V | $4,308 |
| South America | 3 | Program Services | See Part V | $5,242 |
| Central America and the Caribbean | Investments | $8,300,000 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Employees | 60 | SubtotalEmployeesCnt |
| Total Employee | 78 | TotalEmployeeCnt |
| Subtotal Spent | $8,476,245 | SubtotalSpentAmt |
| Total Spent | $8,476,245 | TotalSpentAmt |
| Transfer To Foreign Corp | Yes (true) | TransferToForeignCorpInd |
| Interest In Foreign Trust | false | InterestInForeignTrustInd |
| Foreign Corp Ownership | Yes (true) | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | Yes (true) | PassiveForeignInvestmestCoInd |
| Foreign Partnership | false | ForeignPartnershipInd |
| Boycott Countries | false | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail (3 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| SCHEDULE F, PART I, LINE 3 | PROGRAM SERVICE ACTIVITIES SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE DOES NOT MAINTAIN ONGOING OPERATIONS IN FOREIGN JURISDICTIONS. HOWEVER, THE INSTITUTE'S SCIENTISTS DO TRAVEL TO VARIOUS SCIENTIFIC CONFERENCES IN OTHER COUNTRIES TO SHARE THE INSTITUTE'S SCIENTIFIC DISCOVERIES AND TO LEARN FROM OTHER SCIENTISTS ACROSS THE WORLD. |
| SCHEDULE F, PART I, LINE 3, COLUMN E | TYPE OF SERVICE SPECIFIC PROGRAM SERVICE ACTIVITY IN ALL REGIONS IS AGENTS ATTENDING AND/OR SPEAKING AT SCIENTIFIC CONFERENCES AND COLLABORATIONS. |
| SCHEDULE F, PART I, LINE 3, COLUMN F | ACCOUNTING METHOD THE ACCRUAL METHOD OF ACCOUNTING WAS USED TO DETERMINE THE AMOUNTS IN PART I, LINE 3, COLUMN F. |
Schedule G IRS990ScheduleG
Fundraiser Activity Info FundraiserActivityInfoGrp (2 entries)
| ActivityActivityTxt | Fundraiser Control Of FundsFundraiserControlOfFundsInd |
|---|---|
| ED GILLENWATERS | |
| CONSULTING | false |
| BLAIR BLUM PARTNERS | |
| CONSULTING | false |
Fundraising Event Information FundraisingEventInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Event1 | GALA | Event1Nm |
| Gross Receipts Event1 | $602,005 | GrossReceiptsEvent1Amt |
| Charitable Contri Event1 | $575,005 | CharitableContriEvent1Amt |
| Gross Revenue Event1 | $27,000 | GrossRevenueEvent1Amt |
| Food And Beverage Event1 | $60,882 | FoodAndBeverageEvent1Amt |
| Entertainment Event1 | $43,062 | EntertainmentEvent1Amt |
| Other Direct Expenses Event1 | $59,163 | OtherDirectExpensesEvent1Amt |
| Event2 | BRING IT | Event2Nm |
| Gross Receipts Event2 | $166,160 | GrossReceiptsEvent2Amt |
| Charitable Contri Event2 | $136,160 | CharitableContriEvent2Amt |
| Gross Revenue Event2 | $30,000 | GrossRevenueEvent2Amt |
| Rent Facility Costs Event2 | $5,656 | RentFacilityCostsEvent2Amt |
| Food And Beverage Event2 | $48,873 | FoodAndBeverageEvent2Amt |
| Entertainment Event2 | $1,500 | EntertainmentEvent2Amt |
| Other Direct Expenses Event2 | $61,107 | OtherDirectExpensesEvent2Amt |
| Other Events Total | 0 | OtherEventsTotalCnt |
| Gross Receipts Total | $768,165 | GrossReceiptsTotalAmt |
| Charitable Contributions Tot | $711,165 | CharitableContributionsTotAmt |
| Gross Revenue Total Events | $57,000 | GrossRevenueTotalEventsAmt |
| Rent Fclty Costs Total Events | $5,656 | RentFcltyCostsTotalEventsAmt |
| Food And Beverage Total Events | $109,755 | FoodAndBeverageTotalEventsAmt |
| Entertainment Total Events | $44,562 | EntertainmentTotalEventsAmt |
| Oth Direct Expnss Total Events | $120,270 | OthDirectExpnssTotalEventsAmt |
| Direct Expense Summary Events | $280,243 | DirectExpenseSummaryEventsAmt |
| Net Income Summary | -$223,243 | NetIncomeSummaryAmt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| First Class Or Charter Travel | Yes (X) | FirstClassOrCharterTravelInd |
| Club Dues Or Fees | Yes (X) | ClubDuesOrFeesInd |
| Written Policy Ref T And E Expnss | Yes (true) | WrittenPolicyRefTAndEExpnssInd |
| Substantiation Required | Yes (true) | SubstantiationRequiredInd |
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Form990 Of Other Organizations | Yes (X) | Form990OfOtherOrganizationsInd |
| Written Employment Contract | Yes (X) | WrittenEmploymentContractInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | Yes (true) | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | Yes (true) | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | false | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | false | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | false | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | false | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | false | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | Yes (true) | AnyNonFixedPaymentsInd |
| Initial Contract Exception | false | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (9 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PERRY NISEN MD PHD | ||||||||||||||
| CEO | $773,380 | $0 | $337,503 | $0 | $4,250 | $0 | $97,917 | $0 | $24,262 | $0 | $1,237,312 | $0 | $0 | $0 |
| GARY CHESSUM | ||||||||||||||
| CFO | $362,441 | $0 | $54,001 | $0 | $2,468 | $0 | $12,000 | $0 | $24,262 | $0 | $455,172 | $0 | $0 | $0 |
| GARY RAISL ED D | ||||||||||||||
| FORMER EVP/CAO/CFP/TREASURER | $0 | $0 | $0 | $365,372 | $0 | $0 | $0 | $0 | $0 | $365,372 | $0 | $0 | $0 | |
| GARTH POWIS PHD | ||||||||||||||
| CENTER DIRECTOR | $448,257 | $0 | $50,000 | $0 | $5,721 | $0 | $26,500 | $0 | $15,859 | $0 | $546,337 | $0 | $0 | $0 |
| DANIEL KELLY MD | ||||||||||||||
| CNTR DIR/SCI DIR AT LK NONA | $497,773 | $0 | $0 | $0 | $4,250 | $0 | $26,500 | $0 | $24,231 | $0 | $552,754 | $0 | $0 | $0 |
| EDWARD LEWANDOWSKI | ||||||||||||||
| PROFESSOR | $307,210 | $0 | $208,363 | $0 | $3,008 | $0 | $0 | $0 | $23,914 | $0 | $542,495 | $0 | $0 | $0 |
| CARL WARE PHD | ||||||||||||||
| CENTER DIRECTOR, IIDC | $359,345 | $0 | $53,449 | $0 | $4,741 | $0 | $26,500 | $0 | $16,116 | $0 | $460,151 | $0 | $0 | $0 |
| MICHAEL JACKSON PHD | ||||||||||||||
| DRUG DISCOVERY & DEV, SR VP | $374,240 | $0 | $55,698 | $0 | $3,133 | $0 | $26,500 | $0 | $23,955 | $0 | $483,526 | $0 | $0 | $0 |
| KRISTIINA VUORI MD PHD | ||||||||||||||
| PRESIDENT | $682,730 | $0 | $202,394 | $0 | $1,558 | $0 | $551,500 | $0 | $14,424 | $0 | $1,452,606 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail (5 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, SCHEDULE J, PART I, LINE 1A | FIRST CLASS TRAVEL FIRST CLASS TRAVEL IS GENERALLY NOT PERMITTED, EXCEPT UNDER VERY LIMITED AND RARE CIRCUMSTANCES AND CONDITIONS, SUCH AS A MEDICAL CONDITION REQUIREMENT AND URGENT CIRCUMSTANCES. THIS WAS NOT TREATED AS TAXABLE COMPENSATION. HEALTH OR SOCIAL CLUB DUES HEALTH OR SOCIAL CLUB DUES ARE NEGOTIATED IN THE HIRING PROCESS FOR CERTAIN EMPLOYEES. THE AMOUNTS WERE TREATED AS TAXABLE COMPENSATION. |
| FORM 990, SCHEDULE J, PART I, LINE 4A | DURING THE YEAR THE ORGANIZATION PAID SEVERANCE UNDER A CONFIDENTIAL SEVERANCE AGREEMENT TO ONE INDIVIDUAL. |
| FORM 990, SCHEDULE J, PART I, LINE 4B | SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN THE PARTICIPANTS OF THE 457(F) DEFERRED COMPENSATION PLAN ARE KRISTIINA VUORI AND PERRY NISEN. VESTING FOR KRISTIINA VUORI OCCURS THE EARLIEST OF 4/1/2020 & PERRY NISEN THE EARLIEST OF 9/15/19, OR INVOLUNTARY TERMINATION WITHOUT CAUSE, OR PARTICIPANT'S RESIGNATION FOR GOOD CAUSE, OR THE DATE OF TERMINATION OF THE PLAN. DISTRIBUTION IS A ONE-TIME LUMP SUM PAYMENT UPON VESTING OF 100% OF THE VALUE OF THE PARTICIPANT'S INVESTMENT (COMPRISED OF INSTITUTE CONTRIBUTIONS TO THE CORPUS PLUS ANY INVESTMENT GAINS OR LOSSES THEREON). |
| FORM 990, SCHEDULE J, PART I, LINE 7 | NON-FIXED PAYMENTS SOME SENIOR EXECUTIVES HAVE EMPLOYMENT AGREEMENTS STIPULATING A BONUS WILL BE PAID TO THEM PROVIDED CERTAIN GOALS OR ACCOMPLISHMENTS ARE ACHIEVED. |
| FORM 990, SCHEDULE J, PART II, COLUMN (C) | RETIREMENT AND OTHER DEFERRED COMPENSATION THE AMOUNT REPORTED IN SCHEDULE J, PART II, COLUMN C FOR KRISTIINA VUORI AND PERRY NISEN INCLUDES AN ACCRUAL OF $525,000 AND $79,167 RESPECTIVELY RELATED TO THE 457 (F) PLAN DESCRIBED ABOVE. THESE AMOUNTS ARE NOT VESTED AND ARE SUBJECT TO SUBSTANTIAL RISK OF FORFEITURE. |
Schedule K IRS990ScheduleK
Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bond Reference | A | BondReferenceCd |
Issuer Name IssuerName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | COUNTY OF SAN DIEGO | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bond Issuer EIN | 956000934 | BondIssuerEIN |
| CUSIP | 79742YAQ5 | CUSIPNum |
| Bond Issued | 2015-11-12 | BondIssuedDt |
| Issue Price | $61,963,256 | IssuePriceAmt |
| Purpose | SEE PART VI | PurposeDesc |
| Defeased | false | DefeasedInd |
| On Behalf Of Issuer | false | OnBehalfOfIssuerInd |
| Pool Financing | false | PoolFinancingInd |
Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bond Reference | A | BondReferenceCd |
| Retired | $0 | RetiredAmt |
| Bond Defeased | $61,673,870 | BondDefeasedAmt |
| Total Proceeds | $61,963,256 | TotalProceedsAmt |
| In Reserve Fund | $0 | InReserveFundAmt |
| Capitalized Interest | $0 | CapitalizedInterestAmt |
| Refunding Escrow | $0 | RefundingEscrowAmt |
| Issuance Costs From Proceeds | $289,386 | IssuanceCostsFromProceedsAmt |
| Credit Enhancement | $0 | CreditEnhancementAmt |
| Working Capital Expenditures | $0 | WorkingCapitalExpendituresAmt |
| Capital Expenditures | $0 | CapitalExpendituresAmt |
| Other Spent Proceeds | $0 | OtherSpentProceedsAmt |
| Unspent | $0 | UnspentAmt |
| Substantial Completion | 2015 | SubstantialCompletionYr |
| Current Refunding | Yes (true) | CurrentRefundingInd |
| Advance Refunding | false | AdvanceRefundingInd |
| Final Allocation Made | Yes (true) | FinalAllocationMadeInd |
| Adequate Books And Rec Maint | Yes (true) | AdequateBooksAndRecMaintInd |
Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bond Reference | A | BondReferenceCd |
| Owning Bond Financed Property | false | OwningBondFinancedPropertyInd |
| Any Lease Arrangements | Yes (true) | AnyLeaseArrangementsInd |
| Mgmt Contract Bond Fincd Prop | Yes (true) | MgmtContractBondFincdPropInd |
| Engage Bond Counsel Contracts | Yes (true) | EngageBondCounselContractsInd |
| Any Research Agreements | Yes (true) | AnyResearchAgreementsInd |
| Engage Bond Counsel Research | Yes (true) | EngageBondCounselResearchInd |
| Private Bus Use By Others | 0.01570 | PrivateBusUseByOthersPct |
| Total Private Business Use | 0.01570 | TotalPrivateBusinessUsePct |
| Bond Iss Meet Prvt Sec Pymt Test | false | BondIssMeetPrvtSecPymtTestInd |
| Change In Use Bond Financed Prop | false | ChangeInUseBondFinancedPropInd |
| Remedial Action Taken | false | RemedialActionTakenInd |
| Procs Nonqualified Bond Remdtd | false | ProcsNonqualifiedBondRemdtdInd |
Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bond Reference | A | BondReferenceCd |
| Form8038 T Filed | false | Form8038TFiledInd |
| Rebate Not Due Yet | Yes (true) | RebateNotDueYetInd |
| Exception To Rebate | false | ExceptionToRebateInd |
| No Rebate Due | false | NoRebateDueInd |
| Variable Rate Issue | Yes (true) | VariableRateIssueInd |
| Hedge Identified In Bks And Rec | false | HedgeIdentifiedInBksAndRecInd |
Hedge Provider Name HedgeProviderName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | 0 | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Proceeds Invested In GIC | false | GrossProceedsInvestedInGICInd |
GIC Provider Name GICProviderName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | 0 | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Proceeds Invested | false | GrossProceedsInvestedInd |
| Written Proc To Monitor Reqs | false | WrittenProcToMonitorReqsInd |
Procedures Corrective Action ProceduresCorrectiveActionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bond Reference | A | BondReferenceCd |
| Procedures Corrective Action | false | ProceduresCorrectiveActionInd |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| SCHEDULE K, PART I, ROW A, COLUMN (F) | Refinance 2006 and 2012 bonds with issue dates of 02/01/2006 and 11/15/2012, respectively. |
| SCHEDULE K, PART I, ROW A | For the bond issues listed in Part I, the alternative period used for the reporting requirements in this section is the twelve months ended December 31, 2016. |
Schedule L IRS990ScheduleL
Loans Btwn Org Interested Prsn LoansBtwnOrgInterestedPrsnGrp (2 entries)
| Relationship With OrgRelationshipWithOrgTxt | Loan PurposeLoanPurposeTxt | Loan From OrganizationLoanFromOrganizationInd | Original PrincipalOriginalPrincipalAmt | Balance DueBalanceDueAmt | DefaultDefaultInd | Board Or Committee ApprovalBoardOrCommitteeApprovalInd | Written AgreementWrittenAgreementInd |
|---|---|---|---|---|---|---|---|
| GARY RAISL | |||||||
| FORMER OFFICER | Relocation Loan | Yes (X) | $225,000 | $193,137 | false | Yes (true) | Yes (true) |
| PERRY NISEN | |||||||
| OFFICER | QUAL. EMPLOYEE RELOC | Yes (X) | $1,000,000 | $944,444 | false | Yes (true) | Yes (true) |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Balance Due | $1,137,581 | TotalBalanceDueAmt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (7 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART I, LINE 1 & PART III, LINE 1 | ORGANIZATIONS MISSION SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CONDUCTS WORLD-CLASS, COLLABORATIVE RESEARCH DEDICATED TO FINDING CURES FOR HUMAN DISEASE, IMPROVING THE QUALITY OF LIFE, AND THUS CREATING A LEGACY FOR ITS EMPLOYEES, PARTNERS, DONORS, AND COMMUNITY. |
| FORM 990, PART III, LINE 4 | PROGRAM SERVICE ACCOMPLISHMENTS SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE (SBP) IS AN INDEPENDENT NONPROFIT MEDICAL RESEARCH ORGANIZATION THAT CONDUCTS WORLD-CLASS, COLLABORATIVE, BIOLOGICAL RESEARCH AND TRANSLATES ITS DISCOVERIES FOR THE BENEFIT OF PATIENTS. SBP FOCUSES ITS RESEARCH ON CANCER, IMMUNITY, NEURODEGENERATION, METABOLIC DISORDERS AND RARE CHILDREN'S DISEASES. CANCER Insights on the addictions of tumors. Maria Diaz-Meco, Ph.D., professor in the Cancer Metabolism and Signaling Networks Program, published a study in Cell Metabolism that illustrates how tumors can re-wire their surroundings to ensure access to the substances that enable their survival and feed their growth. Targeting the mechanisms that feed their addictions, including the p62 protein located in the tissue surrounding tumors, may lead to more efficacious and less toxic therapies. Biomarker may predict early Alzheimers disease. A new study from Erkki Ruoslahti, M.D., Ph.D., distinguished professor in the Tumor Microenvironment and Cancer Immunology Program, was published in Nature Communications. The study identifies a peptide that may lead to the early detection of Alzheimers disease. The peptide recognizes a protein that is elevated in the brain blood vessels of a mouse model of Alzheimers disease as well as human patients. Stopping pancreatic cancer before it starts. A study co-authored by Jorge Moscat, Ph.D., and Maria Diaz-Meco, Ph.D. and published in Cancer Cell, looks at ways to detect and stop precursors of pancreatic cancer-called PanIN1 lesions-before they become cancer. The findings suggest small molecules that inhibit a protein called MDM2, which is involved in pancreatic cancer progression, may be effective at preventing PanIN1 lesions from turning malignant. How SHARPIN promotes cancer progression. Zeev Ronai, Ph.D., led an international research collaboration showing how the SHARPIN protein acts as a master switch that controls several other proteins linked to melanoma. Inhibiting SHARPIN makes certain types of tumor cells more susceptible to death, and could boost the overall effectiveness of certain anti-cancer therapies. The paper was published in JCI. DISORDERS OF METABOLISM Drug reverses type 2 diabetes in mice. Anthony Pinkerton, Ph.D., and Robert Liddington, Ph.D., worked with Nunzio Bottini, M.D., Ph.D., (UCSD) on a new experimental drug that may spell the end of insulin reliance. The promising drug targets an enzyme (LMPTP) that controls insulin receptor signaling, and helps recover insulin responsiveness. The paper was published in Nature Chemical Biology. More optimization and testing are needed before proven safe for human studies. IMMUNITY Engineering drugs turning on immune checkpoints. John Sedy, Ph.D.,and Carl Ware, Ph.D., laboratory successfully developed a prototype biologic that can tone down the immune system for potential use in patients with autoimmune diseases. The research, published in JBC, describes a drug created from the check point regulator known as herpesvirus entry mediator (HVEM). New Zika virus inhibitor identified. Alexey Terskikh, Ph.D., Alex Strongin, Ph.D., published research in Antiviral Research on a protease inhibitor that blocks Zika virus propagation in human cells and in mice. The molecule appears to be more potent than previously identified inhibitors of the virus, advancing efforts toward a drug to treat Zika infections. Research could lead to better vaccines and antivirals Sumit Chanda, Ph.D., led research that identifies a new regulator of the innate immune response-the immediate, natural response to foreign invaders. The research published in Nature Microbiology suggests that modulating the regulator-an immune checkpoint called KHSRP-may represent the next generation of antiviral drugs, vaccine adjuvants and immunotherapies. Research to combat biothreat of "Black Death". Francesca Marassi, Ph.D., has developed a way to visualize the protein that makes plague bacteria (Y. pestis) so lethal. Although an old disease, the danger to create and use antibiotic-resistant strains as weapons is a real threat. The research, which was published in the Journal of Biomolecular NMR is advancing our understanding of the infectious process. |
| NEUROSCIENCE AND AGING | Bipolar disorder discovery could lead to new therapies An international study led by Evan Snyder, M.D., Ph.D., identified the molecular mechanism behind lithiums effectiveness in treating bipolar disorder. The findings, which were published in PNAS, are the first to explain how the disease is rooted in a physiological difference in the regulation of CRMP2-an intracellular protein that regulates neural networks. A protein called SORLA protects against neurodegeneration. Huaxi Xu, Ph.D., professor in the Degenerative Diseases Program, published research in Nature Communications explaining how a brain protein called SORLA protects against Alzheimers disease. The observations suggest that early-stage Alzheimers could be treated with drugs that increase levels of SORLA, or that enhance its interaction with certain receptors in the brain. Inflammaging-when the immune system runs awry with age. Peter Adams, Ph.D., professor in the Tumor Initiation and Maintenance Program, published a study on "inflammaging", a state of chronic, low-grade inflammation linked to age-related diseases such as rheumatoid arthritis, liver disease, atherosclerosis and cancer. The research, published in Nature, is the first to describe how DNA can leak from the cell nucleus and trigger an inflammatory response that harms normal tissue. Fruit flies journey to space to study zero gravity on the heart Karen Ocorr, Ph.D., launched an experiment sending six boxes of fruit flies to the International Space Station (ISS) to study the impact of weightlessness on the heart. The study may help uncover therapies to prevent or treat heart conditions, both in space and on earth. Scientists take a deeper dive into cellular trash Malene Hansen, Ph.D., led the first-ever comprehensive analysis of autophagy in a living animal (C. elegans) during aging. Increasingly, defective autophagy is being linked to age-related disease such as cancer, neurodegeneration, and heart disease. The research published in eLIFE provides information on potential future interventions to help people live longer, healthier lives. CHILDREN'S HEALTH New clues to treat Alagille syndrome. Duc Dong, Ph.D., published a paper in Nature Communications that identifies the cells and genes necessary to make liver ducts-thin tubes that transport bile from the liver to the gallbladder and small intestine. The research, performed in a zebrafish genetic model, is especially meaningful for patients with Alagille syndrome, many of whom suffer from jaundice, liver disease and require liver transplants. Bioinformatics & Structural Biology Genome study links over 100 genetic positions to metabolite levels. Tao Long, Ph.D., led the largest study yet to examine which genes influence the amount of hundreds of different metabolites-the byproducts of metabolism. The research published in Nature Genetics is a step toward measuring metabolite levels to help diagnose diseases. TRANSLATIONAL MEDICINE Innovations in neuron monitoring. The Prebys Centers Anne Bang, Ph.D., is pairing with Shadi Dayeh, Ph.D., (UCSD) to develop new technology to make high-sensitivity recordings in neuronal networks possible, with the goal of developing a device that could be implanted into the brain. Current technology to monitor a neurons health, activity and response to drugs can only study one cell for a brief period of time, and often destroys the cell. This presents a barrier to use in the clinic as well as to study neurons as they actually function-in networks. Drs. Bang and Dayeh received an NSF grant entitled, "Scalable and Fab Compatible High-Density Nanowire Arrays for High Throughput Drug Screening" to advance this research. NCI Chemical Biology Consortium awards two cancer therapeutics projects to SBP. The National Cancer Institutes Experimental Therapeutics Program (NExT) seeks to advance clinical practice and bring improved therapies to patients with cancer by supporting the most promising new drug discovery and development projects. They have recently identified two promising new projects from faculty labs at SBP. Lutz Tautz, Ph.D., and Nick Cosford, Ph.D., have received an award for drug discovery efforts looking to inhibit SHP2, a target implicated in a number of cancers, most notably leukemias, and HER2-postive and triple-negative breast cancers. Jorge Moscat, Ph.D., and Maria Diaz-Meco, Ph.D., are leading a project that targets the protein PHGDH and was also selected to enter the Consortium portfolio, attracting an award of $1.65MM for the initial phases of drug discovery, which included both high throughput screening, medicinal chemistry and structure-based drug design. The Prebys Center, as a dedicated center for this NCI Consortium, has been tasked to work on both of these projects to prosecute the early stages of drug screening with the initial goal of identifying and validating chemical hits prior to moving into more advanced stages of drug discovery. Translational Programs Outreach. With great pleasure, we announce Thomas "T.C." Chung, Ph.D., has rejoined the Institute to spearhead Translational Programs Outreach at the Prebys Center. Dr. Chung previously managed the Molecular Libraries Probe Production Center at SBP, a NIH Common Fund supported program intended to identify new drug targets, particularly in areas of unmet medical needs and rare diseases. In his new role, Dr. Chung will work with PIs at SBP and collaborating Institutes to help translate new discoveries in the molecular and cellular basis of disease through initiating drug discovery projects, with the overall aim of stimulating therapeutic innovations. In September, DSI and SBP announced the launch of a phase 1 clinical trial of a lead compound for the potential treatment of calcification diseases. The ascending dose study in health volunteers is nearly complete, and the compound shows excellent human pharmacokinetics and has been well tolerated thus far. Also the NAMPT project, which originated in the laboratory of Steve Gardell, Ph.D. and was executed in collaboration with the Prebys Center, has delivered a series of proprietary molecules with potential for the treatment of heart failure and muscle degeneration. with the Prebys Center, has delivered a series of proprietary molecules with potential for the treatment of heart failure and muscle degeneration. |
| FORM 990, PART VI, LINE 11B | PROCESS USED BY MANAGEMENT AND/OR GOVERNING BODY TO REVIEW FORM 990 THE 990 IS PREPARED BY THE FINANCE DEPARTMENT. IT IS REVIEWED BY THE INSTITUTE'S TAX ADVISORS, SELECTED MEMBERS OF MANAGEMENT INCLUDING THE CFO AND AUDIT COMMITTEE AND PROVIDED TO MEMBERS OF THE BOARD PRIOR TO FILING. |
| FORM 990, PART VI, LINE 12C | DESCR OF PROCESS TO MONITOR TRANSACTIONS FOR CONFLICT OF INTEREST CONFLICT OF INTEREST STATEMENTS ARE GIVEN TO MANAGEMENT STAFF AND PRINCIPAL INVESTIGATORS ON A PERIODIC BASIS TO REPORT ON CONFLICTS OR LACK OF CONFLICTS. THE STATEMENTS ARE REVIEWED ANNUALLY BY THE SENIOR DIRECTOR, INTELLECTUAL PROPERTY AND THE SENIOR DIRECTOR, SPONSORED RESEARCH, WITH A SUMMARY OF THE REVIEW PROVIDED TO THE CFO. AN ASSESSMENT IS MADE AS TO WHETHER A CONFLICT CAN BE MANAGED BY THE EXISTING DEPARTMENTS AND PRACTICES. CONFLICTS ARE BROUGHT TO THE BOARD OF TRUSTEES ON AN AS NEEDED BASIS. CONFLICTS AND POTENTIAL CONFLICTS THAT INVOLVE THE CEO OR THE PRESIDENT ARE BROUGHT TO THE BOARD OF TRUSTEES TO ADDRESS ANY ACTUAL OR POTENTIAL POSSIBILITY THAT THE DESIGNATED REVIEWERS (I.E., SENIOR DIRECTOR, INTELLECTUAL PROPERTY AND THE SENIOR DIRECTOR, SPONSORED RESEARCH, AND THE CFO) COULD BE PRESSURED TO MAKE BIASED DECISIONS IN MANAGING CONFLICTS INVOLVING THE CEO OR PRESIDENT. AS TO RESTRICTIONS IMPOSED: THE INSTITUTE WILL EMPLOY THE MECHANISM THAT IS THE BEST FIT WITH THE FACTS AND CIRCUMSTANCES OF ANY IDENTIFIED CONFLICT OF INTEREST. METHODS TO MANAGE POTENTIAL CONFLICTS/ENFORCEMENT MECHANISM: REVIEWING MANAGEMENT IS RESPONSIBLE FOR MANAGING, REDUCING, OR ELIMINATING REAL OR POTENTIAL CONFLICTS OF INTEREST. EXAMPLES OF CONDITIONS OR RESTRICTIONS THAT MIGHT BE IMPOSED TO MANAGE, REDUCE, OR ELIMINATE CONFLICTS OF INTERESTS INCLUDE: -PUBLIC DISCLOSURE OF SIGNIFICANT FINANCIAL INTERESTS -MONITORING OF RESEARCH BY INDEPENDENT REVIEWERS -MODIFICATION OF THE RESEARCH PLAN -DISQUALIFICATION FROM PARTICIPATION IN THE PORTION OF FUNDED RESEARCH THAT COULD BE AFFECTED BY SIGNIFICANT FINANCIAL INTEREST -DIVESTITURE OF SIGNIFICANT FINANCIAL INTERESTS -SEVERANCE OF RELATIONSHIPS THAT CREATE ACTUAL OR POTENTIAL CONFLICTS -REVIEW OF COMMERCIAL SPONSORED RESEARCH AGREEMENTS FOR SCIENTIFIC MERIT BY THE PROGRAM PLANNING COMMITTEE -REMOVAL OF AN AFFECTED PARTY FROM NEGOTIATION WITH A COMPANY WITH WHICH HE/SHE HAS SIGNIFICANT FINANCIAL INTEREST. |
| FORM 990, PART VI, LINE 15A & 15B | PROCESS FOR DETERMINING COMPENSATION COMPENSATION FOR THE CEO, THE PRESIDENT, CHIEF FINANCIAL OFFICER, AND OTHER KEY EMPLOYEES IS ESTABLISHED ACCORDING TO INSTITUTE POLICIES WHICH ARE DESIGNED TO MEET THE IRS STANDARD FOR "REBUTTABLE PRESUMPTION OF REASONABLENESS". THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES, CONSISTING OF FOUR INDEPENDENT TRUSTEES, REVIEWS COMPARABILITY DATA PROVIDED BY AN INDEPENDENT EXTERNAL CONSULTANT THAT INCORPORATES AND EVALUATES INSTITUTE DATA AND THAT OF COMPARABLE ORGANIZATIONS AND MARKETS FROM WHICH THE INSTITUTE DRAWS ITS EXECUTIVE TALENT. UTILIZING THIS INFORMATION, THE COMPENSATION COMMITTEE, WHICH TYPICALLY SEEKS TO ESTABLISH COMPENSATION BETWEEN THE 50TH AND THE 75TH PERCENTILE OF THE COMPARABILITY DATA, MAKES A DETERMINATION WHETHER THE PROPOSED COMPENSATION IS REASONABLE. THE COMPENSATION COMMITTEE HAS BEEN DELEGATED AUTHORITY BY THE BOARD OF TRUSTEES TO REVIEW AND APPROVE COMPENSATION OF ALL POSITIONS EXCEPT FOR THE CEO. THE CEOS COMPENSATION PACKAGE IS REVIEWED AND APPROVED INITIALLY BY THE COMPENSATION COMMITTEE AND THEN GOES TO THE EXECUTIVE COMMITTEE FOR FINAL APPROVAL. THE COMPENSATION COMMITTEE CONTEMPORANEOUSLY AND ADEQUATELY DOCUMENTS THE BASIS FOR ITS DETERMINATION AND RECOMMENDATION TO THE EXECUTIVE COMMITTEE. IF APPROVED BY THE EXECUTIVE COMMITTEE, THE CEO COMPENSATION PACKAGE IS THEN IMPLEMENTED AND SUCH DOCUMENTATION IS KEPT IN THE WRITTEN AND ELECTRONIC RECORDS OF THE BOARD OF TRUSTEES. THE PROCESS WAS LAST COMPLETED ON JUNE 13, 2017 FOR THE FOLLOWING POSITIONS: 1) CEO 2) PRESIDENT 3) CFO 4) SVP HUMAN RESOURCES 5) VP BUSINESS DEVELOPMENT 6) VP PHILANTHROPY 7) SVP DRUG DISCOVERY & DEVELOPMENT 8) CHIEF SCIENTIFIC ADVISOR/PROFESSOR 9) SCIENTIFC DIRECTOR/PROFESSOR 10) CENTER DIRECTOR/PROFESSOR 11) INFECTIOUS & INFLAMMATORY DISEASE CENTER DIRECTOR/PROFESSOR. |
| FORM 990, PART VI, LINE 19 | PROCESS FOR MAKING DOCUMENTS AVAILABLE TO THE PUBLIC DOCUMENTS ARE AVAILABLE UPON REQUEST. |
Schedule R IRS990ScheduleR
Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp
Disregarded Entity Name DisregardedEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | FL MED DISCOVERY INSTITUTE AT LAKE NONA | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 10901 N TORREY PINES ROAD | AddressLine1Txt |
| City | LA JOLLA | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 92037 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 474997825 | EIN |
| Primary Activities | RESEARCH | PrimaryActivitiesTxt |
| Legal Domicile State | CA | LegalDomicileStateCd |
| Exempt Code Section | 501(c)(3) | ExemptCodeSectionTxt |
| Public Charity Status | 7 | PublicCharityStatusTxt |
Direct Controlling Entity Name DirectControllingEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | SBPMDI | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Controlled Organization | Yes (true) | ControlledOrganizationInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | false | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | false | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | false | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | false | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | false | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | false | DivRelatedOrganizationInd |
| Asset Sale To Other Org | false | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | false | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | false | AssetExchangeInd |
| Rental Of Facilities To Oth Org | false | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | false | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | false | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | false | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | false | SharingOfFacilitiesInd |
| Paid Employees Sharing | false | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | false | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | false | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | false | TransferToOtherOrgInd |
| Transfer From Other Org | false | TransferFromOtherOrgInd |
Comments